首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1316293

全球氧氣療法市場 - 2023-2030 年

Global Oxygen Therapy Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球氧療市場規模達到296 億美元，預計到2030 年將達到476 億美元，實現利潤豐厚的成長。在預測期內（2023-2030 年），全球氧療市場的複合年成長率預計將達到6.3%。家庭護理氧療需求的增加、向輕型攜帶設備的轉變以及對遠程患者監測的日益關注是近期的一些市場趨勢。

近年來，全球氧療市場不斷擴大。氧療是一種醫療干涉措施，包括為呼吸困難或血氧含量低的患者補充氧氣。它用於改善流向人體各組織和器官的氧氣流量，確保足夠的氧含量，從而發揮適當的功能。

全球氧療市場範圍包括氧氣輸送設備等產品，其中包括氧氣濃縮器、氧氣瓶、液氧系統和氧氣面罩，這些產品的使用增加了氧療的市場佔有率。全球氧療市場正在不斷擴大，原因包括呼吸系統疾病發病率不斷上升、老齡化人口不斷增加、醫療保健支出不斷增加以及技術進步等。

市場動態

老齡化人口成長推動氧療市場成長

全球人口迅速老齡化，導致老年人呼吸系統疾病發病率上升。隨著年齡的成長，人們的肺功能會逐漸衰退，因此需要進行氧療。人口老齡化推動了對氧治療設備和服務的需求，尤其是在已開發國家。

例如，根據世界衛生組織（WHO）2022 年的報告，到2030 年，地球上每六個人中就有一個是60 歲或以上的老人。在這個時間跨度內，60 歲及以上人口占世界人口的比例預計將從2020 年的10 億增加到14 億。因此，在預測期內，老齡化人口的成長預計將推動氧療市場的成長。

醫療保健支出成長是全球氧療市場的主要驅動力之一

全球醫療保健支出的增加使氧療市場受益匪淺。各國政府和私營醫療保健提供商正投資於創新醫療技術，如氧療設備，以滿足日益成長的呼吸護理需求。新興經濟體可支配收入的增加和保險涵蓋範圍的擴大也促進了氧氣療法支出的增加。

例如，2022 年6 月，美國國際開發署（USAID）宣布了一項5000 萬美元的計劃，旨在增加全球獲得醫用氧的機會，重點是在全球50 個地區建設和改善醫療保健基礎設施。這項投資預計將支持近2 萬張病床，使每年成千上萬的患者能夠獲得救命的氧氣。

此外，美國還是全球基金最大的捐助國，已捐助6 億多美元用於改善中低收入國家的醫用氧氣供應。自疫情開始以來，美國國際開發署已提供了1.12 億美元的直接資金，用於促進50 個國家的氧氣配送。這些重大投資表明了美國對擴大氧氣治療涵蓋範圍的承諾，預計將對氧氣治療市場產生有利影響。

嚴格的合規性將阻礙市場成長

嚴格的法規阻礙了氧療市場的發展。例如，2023 年5 月，肺纖維化基金會的醫療諮詢委員會發布了一份諮詢聲明，強調必須按照醫護人員的處方使用經FDA 批准的供氧設備。報告警告說，不要在沒有處方的情況下購買供氧設備，這可能會導致嚴重的健康問題。

此外，未經FDA 批准的供氧系統可能無法提供可靠的氧氣供應，這就強調了使用認證設備的重要性。這些法律通過強調患者安全的必要性和通過公認管道持續提供氧氣治療的重要性，起到了限制市場的作用。

COVID-19 影響分析

COVID-19 疫情嚴重影響了全球氧療市場。 COVID-19 病例的增加增加了對氧氣療法的需求，而氧氣療法是治療嚴重呼吸困難的一種急性療法。因此，氧氣出現短缺，需要迅速擴大氧氣生產和基礎設施。

市場的銷售額和收入都出現了成長，而且在危機過去很久之後，這次大流行凸顯了呼吸治療和適當供氧的重要性。遠程病人監護技術的進步進一步改變了市場。然而，不同地區的影響也不盡相同。總之，COVID-19 凸顯了氧氣治療的重要性，並對全球行業產生了持久的影響。

俄烏戰爭影響分析

俄烏衝突對氧療市場產生了重大影響，破壞了醫療設施，造成人口流離失所，並使資源緊張。由於受傷、呼吸系統疾病和與壓力有關的健康問題，衝突提高了對醫用氧氣的需求。然而，基礎設施的損失和供應鏈的中斷使得為有需要的人提供適當的氧氣治療變得十分困難。

此外，將資源分配給快速緊急應變和人道主義援助可能會阻礙長期醫療基礎設施的發展，降低提供全面氧氣治療服務的能力。對氧氣治療行業的具體影響將取決於衝突的持續時間和激烈程度，當地醫療保健提供者和國際援助組織在維持合規性方面發揮著至關重要的作用。

Market Overview

The global oxygen therapy market reached US$ 29.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 47.6 billion by 2030. The global oxygen therapy market is expected to exhibit a CAGR 6.3% during the forecast period (2023-2030). Increasing demand for homecare oxygen therapy, shift towards lightweight and portable devices, and growing focus on remote patient monitoring are some recent market trends.

The global oxygen therapy market has been expanding continuously in recent years. Oxygen therapy is a medical intervention that involves the giving of supplemental oxygen to those who have difficulty breathing or have low levels of oxygen in their blood. It is used to improve the oxygen flow to various body beings tissues and organs, ensuring enough oxygenation for appropriate functioning.

The global oxygen therapy market scope comprises components encompassing its products such as oxygen delivery devices, including oxygen concentrators, oxygen cylinders, liquid oxygen systems, and oxygen masks which has increased usage of oxygen therapy market share. The global market for oxygen therapy is expanding as a result of factors including increasing prevalence of respiratory diseases, growing aging population, rising healthcare expenditure, and technological advances.

Market Dynamics

Growing Aging Population to Drive the Growth of the Oxygen therapy Market

The global population is rapidly aging, resulting in an increased prevalence of respiratory problems among the elderly. As people age, their lung function deteriorates, necessitating the need for oxygen therapy. The need for oxygen therapy devices and services is being driven by an aging population, particularly in developed nations.

For instance, according to World Health Organization (WHO) 2022 report, by 2030, about one out of every six people on the planet will be 60 or older. Within this time span, the share of the world population aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion. As a result, the growing aging population is expected to fuel the growth of the oxygen therapy market over the forecast period.

Increasing Healthcare Expenditure is one of the Major Driver in the Global Oxygen Therapy Market

The global increase in expenditure on healthcare has benefited the oxygen therapy market. Governments and private healthcare providers are investing in innovative medical technologies, such as oxygen therapy equipment, to address the growing need for respiratory care. Rising disposable incomes and expanded insurance coverage in emerging economies have also contributed to greater spending on oxygen therapy.

For instance, on June 2022, U.S. Agency for International Development (USAID) has announced a $50 million initiative to increase global access to medical oxygen, with a focus on the construction and improvement of healthcare infrastructure in fifty areas throughout the world. This investment is expected to support nearly 20,000 beds, allowing hundreds of thousands of patients each year to receive life-saving oxygen.

Furthermore, the U.S. is the greatest donor to The Global Fund, having contributed more than $600 million to improve access to medical oxygen in low- and middle-income nations. Since the beginning of the epidemic, USAID has provided direct funding of $112 million to boost oxygen distribution in 50 countries. These significant investments show a commitment to expanding access to oxygen therapy and are projected to have a beneficial influence on the oxygen therapy market.

The Stringent Regulatory Compliance will Hamper the Growth of the Market

The oxygen therapy market is hampered by stringent regulations. For instance, on May 2023, The Pulmonary Fibrosis Foundation's medical advisory board has issued an advisory statement emphasizing the necessity of utilizing only FDA-approved oxygen delivery equipment as prescribed by healthcare professionals. The report warns against buying oxygen supply equipment without a prescription, which might lead to significant health issues.

Furthermore, non-FDA-authorised oxygen delivery systems may not provide a reliable oxygen supply, emphasizing the importance of using certified equipment. These laws operate as market restraints by emphasizing the necessity of patient safety and the consistent delivery of oxygen therapy via recognized channels.

COVID-19 Impact Analysis

The COVID-19 epidemic severely impacted the global oxygen therapy market. The increase in COVID-19 cases increased the need for oxygen therapy, an acute treatment for severe respiratory distress. As a result, there were shortages, necessitating quick scaling of oxygen production and infrastructure.

The market saw an increase in sales and revenue, and the pandemic highlighted the significance of respiratory treatment and appropriate oxygen delivery long after the crisis had passed. Remote patient monitoring advancements altered the market even more. However, the influence differed by region. Overall, COVID-19 highlighted the importance of oxygen therapy and left an everlasting effect on the global industry.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has had a major effect on the oxygen therapy market, disrupting healthcare facilities, displacing populations, and straining resources. Due to injuries, respiratory ailments, and stress-related health difficulties, the conflict has raised the demand for medical oxygen. However, infrastructure loss and disrupted supply chains have made it difficult to offer appropriate oxygen therapy to people in need.

Furthermore, allocating resources to rapid emergency response and humanitarian help may impede long-term healthcare infrastructure development, reducing the capacity to provide comprehensive oxygen treatment services. The specific impact on the oxygen therapy industry will vary depending on the length and intensity of the conflict, with local healthcare providers and international assistance organizations playing critical roles in maintaining compliance.

Segment Analysis

The global oxygen therapy market is segmented based on product, application, end user, and region.

The Chronic Obstructive Pulmonary Disorder (COPD) Segment Accounts for 31.2% of Market Share Owing to the Increasing Prevalence

The Chronic Obstructive Pulmonary Disorder (COPD) segment emerged as the market leader in oxygen therapy. COPD, a progressive lung disease characterized by airflow limitation, has a significant global impact, particularly among smokers and the elderly. COPD patients frequently require long-term oxygen therapy to enhance their oxygen levels and properly control their symptoms.

The global incidence of COPD has resulted in a significant demand for oxygen therapy devices and services tailored to this market segment. For instance, according to World Health Organization (WHO) statistics of 2023, COPD is the third leading cause of death worldwide. Furthermore, COPD has a significant impact, resulting in nearly 3.23 million deaths in 2019.

Moreover, it is worth emphasizing that low- and middle-income countries (LMICs) bear a disproportionately high burden of COPD, accounting for approximately 90% of COPD-related fatalities. Tobacco smoking is a key factor in COPD in high-income countries, accounting for more than 70% of cases. Also, with rising awareness of COPD and a growing need for respiratory assistance among affected persons, the COPD segment has established itself as the market's leading segment, driving overall growth and development.

Geographical Analysis

North America Accounted for Approximately 39.7% of the Market Share Owing to the Increasing Funding For Research Activities

North America is poised to dominate the oxygen therapy market due to rising awareness and a robust regulatory framework. For instance, companies such as Inogen, Inc. on January 2023, have gained key regulatory milestones in the EU and the US, increasing the availability and accessibility of portable oxygen concentrator equipment. This illustrates the company's dedication to providing novel respiratory treatments in the homecare sector.

Furthermore, initiatives such as Hyperbaric Knowledge USA's Hyperbaric Aware national campaign on May 2023, help to raise knowledge about hyperbaric oxygen therapy (HBOT) and its benefits. Collaboration with organizations such as the Undersea and Hyperbaric Medical Society (UHMS) and physician leaders provides vital resources for both patients and clinicians, developing a greater understanding of oxygen therapy. Thus, owing to the above factors the market is expected to grow over the forecast period.

Competitive Landscape

The major global players in the oxygen therapy market include: GE Healthcare, Invacare Corporation, Inogen, IUC Medical (Smiths Medical), HERSILL S.L., Fisher & Paykel Healthcare Limited, Philips Respironics, Inc., DeVilbiss Healthcare, Tecno-Gaz Industries, Allied Healthcare Products, Inc., and among others.

Why Purchase the Report?

To visualize the global oxygen therapy market segmentation based on product, application, end user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of oxygen therapy market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available as excel consisting of key products of all the major players.

The global oxygen therapy market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Respiratory Disease
  - 4.1.1.2. Technological Advancements in Oxygen Therapy Devices
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Oxygen Therapy Equipments
- 4.1.3. Opportunity
  - 4.1.3.1. Increasing Demand for Homecare Oxygen Therapy
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Oxygen Source Equipment*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Oxygen Delivery Devices

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Chronic Obstructive Pulmonary Disease*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Asthma
8.4. Obstructive Sleep Apnea
8.5. Respiratory Distress Syndrome
8.6. Cystic Fibrosis
8.7. Pneumonia
8.8. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Home Healthcare
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. GE Healthcare*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Invacare Corporation
12.3. Inogen
12.4. IUC Medical (Smiths Medical)
12.5. HERSILL S.L.
12.6. Fisher & Paykel Healthcare Limited
12.7. Philips Respironics, Inc.
12.8. DeVilbiss Healthcare
12.9. Tecno-Gaz Industries
12.10. Allied Healthcare Products, Inc.

LIST NOT EXHAUSTIVE